Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination

• Main Authors: Khakshour, D. (Author), Maurer, J.M (Author), Showers, C.R (Author), Shukla, M. (Author)
• Format: Article
• Language: English
• Published: NLM (Medline) 2022
• Subjects: COVID-19; Immunological products and vaccines; Rheumatology; Unwanted effects / adverse reactions; Vaccination/immunisation
• Online Access: View Fulltext in Publisher

 Kawasaki disease (KD) and multisystem inflammatory syndrome (MIS) are rare conditions that occur predominately in children. Recent reports document KD and MIS in adult patients following infection with SARS-CoV-2. Rarely, MIS is observed following vaccination against SARS-CoV-2, mostly in patients with prior SARS-CoV-2 infection. We report a case of KD in a man after a second SARS-CoV-2 vaccine dose, in absence of concurrent or prior SARS-CoV-2 infection. This patient also met criteria for probable MIS associated with vaccination. He tested negative for SARS-CoV-2 RNA via reverse transcriptase PCR, negative for SARS-CoV-2 nucleocapsid antibodies and demonstrated high levels SARS-CoV-2 spike protein antibodies, commonly used to assess vaccine response. Symptom improvement followed treatment with intravenous immunoglobulin, including desquamation of the hands and feet. As widespread vaccination against SARS-CoV-2 continues, increased vigilance and prompt intervention is necessary to limit the effects of postvaccination inflammatory syndromes. © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.